Journey Medical (DERM) Operating Income: 2020-2025
Historic Operating Income for Journey Medical (DERM) over the last 5 years, with Sep 2025 value amounting to -$1.5 million.
- Journey Medical's Operating Income rose 47.17% to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.5 million, marking a year-over-year increase of 69.50%. This contributed to the annual value of -$13.7 million for FY2024, which is 559.77% down from last year.
- Per Journey Medical's latest filing, its Operating Income stood at -$1.5 million for Q3 2025, which was up 46.84% from -$2.9 million recorded in Q2 2025.
- Over the past 5 years, Journey Medical's Operating Income peaked at $17.2 million during Q3 2023, and registered a low of -$13.8 million during Q2 2021.
- Its 3-year average for Operating Income is -$2.1 million, with a median of -$2.9 million in 2024.
- Its Operating Income has fluctuated over the past 5 years, first plummeted by 5,391.21% in 2021, then surged by 281.68% in 2023.
- Over the past 5 years, Journey Medical's Operating Income (Quarterly) stood at -$9.1 million in 2021, then declined by 10.36% to -$10.0 million in 2022, then surged by 78.95% to -$2.1 million in 2023, then soared by 206.18% to $2.2 million in 2024, then skyrocketed by 47.17% to -$1.5 million in 2025.
- Its Operating Income stands at -$1.5 million for Q3 2025, versus -$2.9 million for Q2 2025 and -$3.3 million for Q1 2025.